InsiderClue
← All stocks

BeOne Medicines Ltd.

ONC Mostly scheduled
CIK 0001651308 #603 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$361.20M
$136.75M on a plan · $208.86M straight out of an exercise
Sold at will
$15.59M
55 of 192 sales
Net
−$361.20M
−$15.59M against sales at will

By person

18 insiders · 192 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
OYLER JOHN
Chief Executive Officer
—
$327.88M (121) scheduled
−$327.88M
5,697,649
$2.00B
—
Wang Xiaodong
Director
—
$13.37M (8) scheduled
−$13.37M
4,588,163
$1.61B
−10.9%
Wu Xiaobin
President and COO
—
$8.75M (19)
−$8.75M
1,308,161
$459.50M
+74.4%
Lee Chan Henry
SVP, General Counsel
—
$7.95M (22) scheduled
−$7.95M
346,554
$121.73M
+161.1%
Wang Lai
President, Global Head of R&D
—
$1.17M (5)
−$1.17M
1,710,085
$600.67M
+96.8%
Sanders Corazon (Corsee) D.
Director
—
$961.17K (3) scheduled
−$961.17K
57,226
$20.10M
+23.2%
Rosenberg Aaron
Chief Financial Officer
—
$524.45K (2)
−$524.45K
397,891
$139.76M
+306.6%
BAKER BROS. ADVISORS LP entity
Director
—
$261.98K (4)
−$261.98K
8,229,961
$2.89B
−17.1%
Ball Titus B.
Principal Accounting Officer
—
$127.34K (5)
−$127.34K
97,929
$34.40M
+159.0%
Dugan Margaret
Director
—
$65.64K (1)
−$65.64K
73,164
$25.70M
+68.5%
Riva Alessandro
Director
—
$65.62K (1)
−$65.62K
73,164
$25.70M
+68.5%
Yi Qingqing
Director
—
$65.60K (1)
−$65.60K
27,326
$9.60M
−40.8%
HHLR ADVISORS, LTD. entity
10% owner
—
—
—
125,045,741
$43.92B
−12.5%
HOOPER ANTHONY C
Director
—
—
—
83,720
$29.41M
+55.7%
BRANDICOURT OLIVIER
Director
—
—
—
46,306
$16.27M
+183.4%
Sharp Shalini
Director
—
—
—
38,116
$13.39M
—
Sawyers Charles Lazelle
Director
—
—
—
18,984
$6.67M
+474,500%
Mooney Elizabeth Fisher
Director
—
—
—
18,980
$6.67M
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

55
Insider
Date
Role
Action
Shares
Price
Amount
Ball Titus B.
1 Sep 2026
Principal Accounting Officer
Sell
132
$355.86
$46.97K
Rosenberg Aaron
3 Aug 2026
Chief Financial Officer
Sell
1,157
$312.72
$361.81K
Lee Chan Henry
30 Jul 2026
SVP, General Counsel
Sell
1,044
$323.69
$337.93K
Wang Lai
23 Jun 2026
President, Global Head of R&D
Sell
1,068
$276.74
$295.55K
OYLER JOHN
23 Jun 2026
Chief Executive Officer
Sell
320
$275.10
$88.03K
OYLER JOHN
23 Jun 2026
Chief Executive Officer
Sell
1,290
$274.12
$353.61K
OYLER JOHN
23 Jun 2026
Chief Executive Officer
Sell
1,800
$273.30
$491.95K
Wu Xiaobin
23 Jun 2026
President and COO
Sell
1,292
$276.26
$356.93K
Wang Lai
16 Jun 2026
President, Global Head of R&D
Sell
1,169
$265.39
$310.24K
Lee Chan Henry
16 Jun 2026
SVP, General Counsel
Sell
590
$265.98
$156.93K
OYLER JOHN
16 Jun 2026
Chief Executive Officer
Sell
333
$266.69
$88.81K
OYLER JOHN
16 Jun 2026
Chief Executive Officer
Sell
1,710
$265.99
$454.84K
OYLER JOHN
16 Jun 2026
Chief Executive Officer
Sell
1,650
$264.87
$437.04K
Wu Xiaobin
16 Jun 2026
President and COO
Sell
1,357
$266.76
$362.00K
OYLER JOHN
11 Jun 2026
Chief Executive Officer
Sell
149
$258.81
$38.56K
OYLER JOHN
11 Jun 2026
Chief Executive Officer
Sell
200
$258.28
$51.66K
OYLER JOHN
11 Jun 2026
Chief Executive Officer
Sell
859
$257.59
$221.27K
OYLER JOHN
11 Jun 2026
Chief Executive Officer
Sell
741
$256.23
$189.87K
Lee Chan Henry
11 Jun 2026
SVP, General Counsel
Sell
428
$257.64
$110.27K
Wu Xiaobin
11 Jun 2026
President and COO
Sell
626
$261.20
$163.51K
Rosenberg Aaron
11 Jun 2026
Chief Financial Officer
Sell
631
$257.74
$162.64K
Wang Lai
11 Jun 2026
President, Global Head of R&D
Sell
756
$261.00
$197.32K
Ball Titus B.
11 Jun 2026
Principal Accounting Officer
Sell
120
$257.53
$30.90K
Ball Titus B.
11 Jun 2026
Principal Accounting Officer
Sell
49
$256.39
$12.56K
OYLER JOHN
8 Jun 2026
Chief Executive Officer
Sell
1,120
$271.14
$303.68K
OYLER JOHN
8 Jun 2026
Chief Executive Officer
Sell
3,820
$270.38
$1.03M
Wu Xiaobin
8 Jun 2026
President and COO
Sell
40
$270.55
$10.82K
Wu Xiaobin
8 Jun 2026
President and COO
Sell
1,444
$269.33
$388.92K
Wang Lai
8 Jun 2026
President, Global Head of R&D
Sell
40
$270.73
$10.83K
Wang Lai
8 Jun 2026
President, Global Head of R&D
Sell
1,327
$269.34
$357.42K
Lee Chan Henry
8 Jun 2026
SVP, General Counsel
Sell
160
$271.26
$43.40K
Lee Chan Henry
8 Jun 2026
SVP, General Counsel
Sell
711
$270.24
$192.14K
Ball Titus B.
8 Jun 2026
Principal Accounting Officer
Sell
36
$272.08
$9.79K
Ball Titus B.
8 Jun 2026
Principal Accounting Officer
Sell
100
$271.06
$27.11K
Yi Qingqing
1 Jun 2026
Director
Sell
235
$279.13
$65.60K
BAKER BROS. ADVISORS LP
22 May 2026
Director
Sell indirect
2,756
$23.79
$65.57K
BAKER BROS. ADVISORS LP
22 May 2026
Director
Sell indirect
2,756
$23.79
$65.57K
BAKER BROS. ADVISORS LP
22 May 2026
Director
Sell indirect
2,743
$23.85
$65.42K
BAKER BROS. ADVISORS LP
22 May 2026
Director
Sell indirect
2,743
$23.85
$65.42K
Sanders Corazon (Corsee) D.
22 May 2026
Director
Sell
212
$309.59
$65.63K
Dugan Margaret
22 May 2026
Director
Sell
212
$309.60
$65.64K
Riva Alessandro
22 May 2026
Director
Sell
212
$309.51
$65.62K
Wu Xiaobin
17 Nov 2025
President and COO
Sell
10
$382.32
$3.82K
Wu Xiaobin
17 Nov 2025
President and COO
Sell
826
$381.19
$314.86K
Wu Xiaobin
17 Nov 2025
President and COO
Sell
3,155
$380.23
$1.20M
Wu Xiaobin
13 Nov 2025
President and COO
Sell
1,769
$381.05
$674.08K
Wu Xiaobin
13 Nov 2025
President and COO
Sell
4,240
$380.33
$1.61M
Wu Xiaobin
12 Nov 2025
President and COO
Sell
154
$362.07
$55.76K
Wu Xiaobin
12 Nov 2025
President and COO
Sell
4,846
$360.10
$1.75M
Wu Xiaobin
12 Nov 2025
President and COO
Sell
100
$357.43
$35.74K
Wu Xiaobin
12 Nov 2025
President and COO
Sell
120
$355.00
$42.60K
Wu Xiaobin
12 Nov 2025
President and COO
Sell
251
$354.20
$88.90K
Wu Xiaobin
12 Nov 2025
President and COO
Sell
789
$352.78
$278.34K
Wu Xiaobin
12 Nov 2025
President and COO
Sell
3,240
$351.41
$1.14M
Wu Xiaobin
12 Nov 2025
President and COO
Sell
500
$350.44
$175.22K
Show all 192 transactions →

What was left out

Form 4 filings counted 67
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 54
Sales straight out of an exercise 83
Sales at will 55
Transactions with no price 0
Shares from compensation/vesting 4,398,908
History held since 7 Sep 2016